Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.20.1
Financial Instruments (Tables)
 12 Months Ended
Dec. 31, 2019
Financial Instruments [Abstract]  
Schedule of financial assets

  a. Financial assets:

 

    December 31,  
    2019     2018  
    USD  
Financial assets at fair value through profit or loss (classified as Level 1 in the fair value hierarchy):            
             
Short-term investment   $ 64     $ 273  
Schedule of financial liabilities at fair value through profit or loss

    December 31,  
    2019     2018  
    USD  
Other financial liabilities at amortized cost:                
                 
Trade payable   $ 2,156     $ 1,071  
Other account payable     610       1,122  
Warrants exercisable into shares     1,566       -  
                 
    $ 4,332     $ 2,193  
Schedule of foreign currency sensitivity analysis

    December 31,
2019		     December 31,
2018		  
             
Linked to NIS     9       32  

 
Schedule of fair value measurements using significant unobservable inputs

    USD  
       
Balance at December 31, 2017     -  
         
Changes in values of  warrants exercisable into shares liability     -  
         
Balance at December 31, 2018     -  
         
Fair value of warrants at issuance date     4,603  
Changes in values of  warrants exercisable into shares liability     (3,037 )
         
Balance at December 31, 2019     1,566  
Schdule of fair value of warrants

    December 31,  
    2019  
       
Dividend yield     0  
Expected volatility     63.02%-65.22 %
Risk-free interest     1.69%-1.71 %
Exercise price     3.45-4.00  
Expected life     4.89-5.52